{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0859237/OMIM:619835","label":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","mondoId":"MONDO:0859237","onsetQualifier":null,"recordKeys":["042366204dd2573ef06847998ab840c73d228f72511768efcdd197953962abee","0870d0044da1bbb0d240f02ad717a2447320efdf36d2a43ed546869cc1d68540","0a891b441013794a9442c8d443ce4060b50c02f7e10463fb64b3f7fe80ca7af2","154185d34f6272aaecf091e80a296c9076bbff83b0025228825bf96023b1dd22","321d6cabb5a6df7c9721080ded7ee6291e75063590c6dbc53d5c5777a39ce648","4a920593a1167f472e678227ac0a1bb157d05272dae03443457fa51b6ba3e19b","67255185f4683f24c3cbe5b67a6b8dab662ef2fefca53ccc9eb3661e6f054a10","6eea47cf8dcb6f100baea0050bbbec249545a2c434cc9fc870e14a895180f076","7cb68678d9068ddcc477763bd58a936571743afc3f4cc90498b85ca4cfe3082c","82acaf0e921882f59202443d48a4f2ed79ab9e1a3b2ef51585b5b561be9d318b","a522dc071a88f4824d95eeadf8141699de8cb2dfb4f00fca18da68c1e39c5ee4","aa39bb2576ab0e7e3849d7b4e9590dcbcc7caf9e63c294f8b37d50f30b023f21","aca895ea0fa82dc5934a37558490fbdbadb14e03d5d9f8ea43e27d0e6e02b76f","c3763db4c4c02a0b20a9a08ccfe763a14aba30c951b89bfe116d9e250ce3020d","ceeb103a403df88a229c40ff0a9e8f99dc5e18c2e1ca21c2fe22a1624b8366a6","dbafcd8e86af7a7f6f94264706f2065b273c2126a93e069838d9e0c3d2d2115a","f8850eb67a5a00248c036ea9ddf4343911b619fba10e369c8f40f28294b03970"],"recordQualifiers":{},"scopeLabel":"OMIM:619835","sourceIds":["OMIM:619835"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0859237/OMIM:619835"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":17,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":17,"sourceGroups":{"omim":0,"orphanet":0,"published":17}},"features":[{"hpoId":"HP:0003535","label":"3-Methylglutaconic aciduria","primary":false},{"hpoId":"HP:0002518","label":"Abnormal periventricular white matter morphology","primary":false},{"hpoId":"HP:0001344","label":"Absent speech","primary":false},{"hpoId":"HP:0001903","label":"Anemia","primary":false},{"hpoId":"HP:0004823","label":"Anisopoikilocytosis","primary":false},{"hpoId":"HP:0007270","label":"Atypical absence seizure","primary":false},{"hpoId":"HP:0002069","label":"Bilateral tonic-clonic seizure","primary":false},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":false},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":false},{"hpoId":"HP:0002188","label":"Delayed CNS myelination","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language","primary":false},{"hpoId":"HP:0002197","label":"Generalized-onset seizure","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0032794","label":"Myoclonic seizure","primary":false},{"hpoId":"HP:0032435","label":"Neonatal omphalitis","primary":false},{"hpoId":"HP:0005484","label":"Secondary microcephaly","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0859237","records":[{"frequencyKind":"count","key":"042366204dd2573ef06847998ab840c73d228f72511768efcdd197953962abee","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0004823","is_excluded":false,"label":"Anisopoikilocytosis","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0870d0044da1bbb0d240f02ad717a2447320efdf36d2a43ed546869cc1d68540","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"4/6","hpo_id":"HP:0005484","is_excluded":false,"label":"Secondary microcephaly","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0a891b441013794a9442c8d443ce4060b50c02f7e10463fb64b3f7fe80ca7af2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"2/6","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"154185d34f6272aaecf091e80a296c9076bbff83b0025228825bf96023b1dd22","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"2/6","hpo_id":"HP:0002518","is_excluded":false,"label":"Abnormal periventricular white matter morphology","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"321d6cabb5a6df7c9721080ded7ee6291e75063590c6dbc53d5c5777a39ce648","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0002069","is_excluded":false,"label":"Bilateral tonic-clonic seizure","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4a920593a1167f472e678227ac0a1bb157d05272dae03443457fa51b6ba3e19b","raw":{"aspect":"P","body_system":"prenatal","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0032435","is_excluded":false,"label":"Neonatal omphalitis","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"67255185f4683f24c3cbe5b67a6b8dab662ef2fefca53ccc9eb3661e6f054a10","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6eea47cf8dcb6f100baea0050bbbec249545a2c434cc9fc870e14a895180f076","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0032794","is_excluded":false,"label":"Myoclonic seizure","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7cb68678d9068ddcc477763bd58a936571743afc3f4cc90498b85ca4cfe3082c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"3/6","hpo_id":"HP:0007270","is_excluded":false,"label":"Atypical absence seizure","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"82acaf0e921882f59202443d48a4f2ed79ab9e1a3b2ef51585b5b561be9d318b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"5/6","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a522dc071a88f4824d95eeadf8141699de8cb2dfb4f00fca18da68c1e39c5ee4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aa39bb2576ab0e7e3849d7b4e9590dcbcc7caf9e63c294f8b37d50f30b023f21","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0003535","is_excluded":false,"label":"3-Methylglutaconic aciduria","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aca895ea0fa82dc5934a37558490fbdbadb14e03d5d9f8ea43e27d0e6e02b76f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"5/6","hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c3763db4c4c02a0b20a9a08ccfe763a14aba30c951b89bfe116d9e250ce3020d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0002197","is_excluded":false,"label":"Generalized-onset seizure","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ceeb103a403df88a229c40ff0a9e8f99dc5e18c2e1ca21c2fe22a1624b8366a6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0002188","is_excluded":false,"label":"Delayed CNS myelination","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"dbafcd8e86af7a7f6f94264706f2065b273c2126a93e069838d9e0c3d2d2115a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"1/6","hpo_id":"HP:0001344","is_excluded":false,"label":"Absent speech","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f8850eb67a5a00248c036ea9ddf4343911b619fba10e369c8f40f28294b03970","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619835","disease_name":"3-methylglutaconic aciduria, type VIIA, autosomal dominant","evidence":"PCS","frequency_raw":"4/6","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"PMID:34140661","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"3-methylglutaconic-aciduria-type-viia","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"3-methylglutaconic aciduria, type VIIA"},"schemaVersion":1}